Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Neuroscience
Single-Photon Emission Computed Tomography
100%
Iodine-123
73%
Dopamine Transporter
68%
Translocator Protein
24%
Magnetic Resonance Imaging
21%
In Vivo
16%
Technetium-99m
13%
Exenatide
11%
Glucagon-Like Peptide-1 Agonist
11%
Ictal
10%
Placebo
10%
Alcoholism
10%
Epilepsy
10%
Positron Emission Tomography
10%
Radioligand
10%
Dopaminergic
8%
Dopamine
8%
Molecular Imaging
7%
Glioblastoma Multiforme
7%
Parkinson's Disease
7%
Glucagon-Like Peptide 1 Receptor
6%
Receptor
6%
Acetamide
6%
Parkinsonism
6%
Body Mass Index
6%
Protein Expression
6%
Dopamine Uptake
5%
Post-Concussion Syndrome
5%
Dementia with Lewy Bodies
5%
Neurotrauma
5%
Arterial Spin Labeling
5%
Traumatic Brain Injury
5%
Protein Binding
5%
Neurodegeneration
5%
Brain-Derived Neurotrophic Factor
5%
Serotonin Transporter
5%
Fluorine-18
5%
Multiple System Atrophy
5%
Acetazolamide
5%
Striatum
5%
Keyphrases
Single-photon Emission Computed Tomography (SPECT)
55%
Dopamine Transporter
35%
123I
31%
Striatal Dopamine
27%
PE2I
25%
Dopamine Transporter SPECT
21%
Striatal
14%
Radioligand
13%
Region of Interest
13%
Dopamine Transporter Availability
12%
Dopamine Transporter Binding
12%
123I-FP-CIT SPECT
10%
SISCOM
10%
Methodological Considerations
10%
Epilepsy
10%
Pre-surgical
10%
Interictal
10%
Ictal
10%
Predictive Value
10%
Hypoperfusion
9%
Translocator Protein
8%
Molecular Imaging
7%
Seizure Duration
6%
Healthy Volunteers
6%
Healthy Controls
6%
Positive Predictive Value
6%
Dopamine
6%
Brain Scanning
6%
Patients with Parkinson's Disease
6%
Enzyme-linked Immunosorbent Assay (ELISA)
6%
Imidazo[1,2-a]pyridine
6%
Glucagon-like
5%
Receptor Agonist
5%
SPECT Imaging
5%
Placebo-controlled Clinical Trial
5%
Brain Imaging
5%
Alcohol Intake
5%
Neuroinflammation
5%
Active Smokers
5%
Automatic Delineation
5%
1 Receptor
5%
Highly Reproducible
5%
Non-smokers
5%
Nuclear Medicine
5%
HMPAO
5%
Factor Levels
5%
Intensive Care Unit
5%
HyPer
5%
Technetium-99m
5%
Diagnostic Sensitivity
5%
Medicine and Dentistry
Controlled Clinical Trial
10%
Alcoholic Polyneuropathy
10%
Placebo
10%
Iodine 123
8%
Exenatide
8%
Glucagon-Like Peptide-1 Agonist
8%
Single-Photon Emission Computed Tomography
8%
Alcohol Consumption
7%
Dopamine Transporter
6%
Brain Blood Flow
5%
Parkinson's Disease
5%
Arterial Spin Labeling
5%
Receptor
5%
Intensive Care Unit
5%
Acute Disease
5%
Disorders of Consciousness
5%
Shy-Drager Syndrome
5%
Magnetic Resonance Imaging
5%
Molecular Imaging
5%
Post-Concussion Syndrome
5%
Computed Tomography Studies
5%
Nortropane Derivative
5%
Neuroinflammation
5%
Traumatic Brain Injury
5%
